7์ 25 ๊ฒ์
While global competitors like Volkswagen face billion-dollar tariff costs, these U.S.-based companies enjoy natural protection from import duties. This competitive moat could translate into stronger margins and market share gains.
These companies have substantial U.S. production facilities, positioning them to benefit as trade policies favor domestic manufacturing. Their local operations provide cost advantages that foreign competitors can't easily replicate.
As import tariffs reshape the automotive landscape, these stocks are positioned on the winning side of policy changes. Expert analysts selected this group specifically to capture the potential upside from ongoing trade dynamics.
Volkswagen's recent profit warning, directly tied to U.S. import tariffs costing โฌ1.3 billion, reveals a clear competitive advantage for companies with domestic manufacturing. This group focuses on U.S.-based automakers and parts suppliers who are largely shielded from these import duties, potentially supporting stronger profitability and market positioning as trade policies continue to shape the industry landscape.
This collection includes established U.S. automakers alongside a diverse range of parts suppliers covering everything from powertrain and chassis components to seating and electronics. These companies form the backbone of the American automotive value chain and benefit from having substantial manufacturing operations within the United States, protecting them from the direct cost pressures of vehicle import tariffs.
Each company was handpicked by professional analysts based on their significant domestic manufacturing footprint and position within the U.S. automotive ecosystem. This curated selection offers tactical exposure to firms that stand to benefit from the competitive dynamics created by ongoing trade policies, particularly as global automakers face mounting pressure from import duties and restructuring costs.
This basket's total market capitalisation is $520.03B and is heavily anchored by a small number of very large-cap holdings, producing a predominantly large-cap profile.
GM: $62.15B
F: $49.99B
TM: $322.70B
์ด ๋ฐ์ค์ผ์ ์ ์ฒด ์คํ ๋ฆฌ๋ฅผ ํ์ธํ์ธ์. ๋ฆฌ์คํฌ์ ์ ์ฌ๋ ฅ์ ๋ค๋ฃฌ ์์ธ ๊ธฐ์ฌ๋ฅผ ์ฝ์ด๋ณด์ธ์.
Trade stocks, ETFs, and more with zero commission. Keep more of your returns.
Part of Exinity Group 2015, serving over a million customers globally.
Earn 6% AER on uninvested cash with daily interest payments.
Gilead Sciences has secured FDA approval for a new once-daily HIV combination pill, streamlining therapy for millions of suppressed patients. This regulatory milestone spotlights investment opportunities in pioneering biopharmaceutical companies and drug delivery developers focused on advanced antiviral treatments.
Disney is suing the FCC to block an early license review of its ABC stations, arguing the move is politically motivated retaliation against its news coverage. This unprecedented legal battle highlights the growing regulatory risks for traditional broadcasters and underscores the structural advantages of unregulated digital streaming platforms.
SK Hynix has unveiled a record-breaking 40 trillion won share buyback fueled by soaring demand for its AI memory chips. This historic capital return creates a compelling investment theme centered on high-bandwidth memory producers and the specialized equipment manufacturers that enable their advanced production.
+7
Here are a few of the assets in this group. Create an account to unlock the full list.
Use the growth calculator to see how much investing in these assets could return over one year, based on aggregated analyst sentiment provided by Refinitive Ltd.
์ด ์์ฐ๋ค์ ํฌ์ํ๋ค๋ฉด:
12๊ฐ์ ํ ์์ ๊ฐ์น:
+129.18%
์ ๋๋ฆฌ์คํธ๋ค์ ์ด ๊ทธ๋ฃน์ ์์ฐ์ด ํฅํ 1๋ ๊ฐ ํ๊ท 129.18% ์ฑ์ฅํ ๊ฒ์ผ๋ก ์์ํฉ๋๋ค.
์ด ๊ทธ๋ฃน์ ์์ฐ 17๊ฐ ์ค 14๊ฐ๊ฐ ์ ๋ฌธ ์ ๋๋ฆฌ์คํธ๋ก๋ถํฐ ๋งค์ ์๊ฒฌ์ ๋ฐ์์ต๋๋ค.
